These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1080 related items for PubMed ID: 26317465
1. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, O'Brien C, De Carvalho DD. Cell; 2015 Aug 27; 162(5):961-73. PubMed ID: 26317465 [Abstract] [Full Text] [Related]
2. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells. Takaki H, Honda K, Atarashi K, Kobayashi F, Ebihara T, Oshiumi H, Matsumoto M, Shingai M, Seya T. Mol Immunol; 2014 Feb 27; 57(2):100-10. PubMed ID: 24096085 [Abstract] [Full Text] [Related]
3. DNAJB1/HSP40 Suppresses Melanoma Differentiation-Associated Gene 5-Mitochondrial Antiviral Signaling Protein Function in Conjunction with HSP70. Takashima K, Oshiumi H, Matsumoto M, Seya T. J Innate Immun; 2018 Feb 27; 10(1):44-55. PubMed ID: 29069650 [Abstract] [Full Text] [Related]
5. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine. Karpf AR, Moore BC, Ririe TO, Jones DA. Mol Pharmacol; 2001 Apr 27; 59(4):751-7. PubMed ID: 11259619 [Abstract] [Full Text] [Related]
6. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. Bovenzi V, Momparler RL. Cancer Chemother Pharmacol; 2001 Jul 27; 48(1):71-6. PubMed ID: 11488527 [Abstract] [Full Text] [Related]
7. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia. Momparler RL, Côté S, Eliopoulos N. Leukemia; 1997 Feb 27; 11(2):175-80. PubMed ID: 9009076 [Abstract] [Full Text] [Related]
9. Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells. Côté S, Momparler RL. Anticancer Drugs; 1997 Jan 27; 8(1):56-61. PubMed ID: 9147612 [Abstract] [Full Text] [Related]
10. DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine. Bovenzi V, Lê NL, Côte S, Sinnett D, Momparler LF, Momparler RL. Anticancer Drugs; 1999 Jun 27; 10(5):471-6. PubMed ID: 10477167 [Abstract] [Full Text] [Related]
12. Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Karpf AR, Peterson PW, Rawlins JT, Dalley BK, Yang Q, Albertsen H, Jones DA. Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14007-12. PubMed ID: 10570189 [Abstract] [Full Text] [Related]
13. [5-aza-2'-deoxycytidine suppresses the growth of human lung adenocarcinoma cells in nude mouse xenograft models and its effect on methylation status and expression of TFPI-2 gene]. Liang J, Yin G, Dong Y, Ma Z, Xiao Y, Ji T. Zhonghua Zhong Liu Za Zhi; 2015 Jul 23; 37(7):485-9. PubMed ID: 26463322 [Abstract] [Full Text] [Related]
14. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Côté S, Sinnett D, Momparler RL. Anticancer Drugs; 1998 Oct 23; 9(9):743-50. PubMed ID: 9840718 [Abstract] [Full Text] [Related]
15. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. Pulukuri SM, Rao JS. Int J Oncol; 2005 Apr 23; 26(4):863-71. PubMed ID: 15753979 [Abstract] [Full Text] [Related]
16. Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. Amatori S, Bagaloni I, Viti D, Fanelli M. Lung Cancer; 2011 Jan 23; 71(1):113-5. PubMed ID: 21095037 [Abstract] [Full Text] [Related]
17. Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment. Miasaki FY, Vivaldi A, Ciampi R, Agate L, Collecchi P, Capodanno A, Pinchera A, Elisei R. J Endocrinol Invest; 2008 Aug 23; 31(8):724-30. PubMed ID: 18852534 [Abstract] [Full Text] [Related]
18. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia. Momparler RL, Côté S, Eliopoulos N. Leukemia; 1997 Mar 23; 11 Suppl 1():S1-6. PubMed ID: 9130684 [Abstract] [Full Text] [Related]
19. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia. Lemaire M, Momparler LF, Bernstein ML, Marquez VE, Momparler RL. Anticancer Drugs; 2005 Mar 23; 16(3):301-8. PubMed ID: 15711182 [Abstract] [Full Text] [Related]
20. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium. Broquet AH, Hirata Y, McAllister CS, Kagnoff MF. J Immunol; 2011 Feb 01; 186(3):1618-26. PubMed ID: 21187438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]